Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
poliomyelitis vaccine (vero cells), inactivated, sabin strain
- Development stage
- Unknown
- Lead developer
- Beijing Minhai Biological
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Poliomyelitis vaccine (Vero cells), inactivated, Sabin strain (sIPV) is a trivalent inactivated viral vaccine developed by BioKangtai (through its subsidiary Beijing Minhai Biotechnology) for the active immunization and prevention of poliomyelitis in infants and toddlers. The vaccine is produced by cultivating attenuated Sabin strains of poliovirus (types 1, 2, and 3) in Vero cells, followed by purification and formaldehyde inactivation. Compared to traditional Salk-strain inactivated polio vaccines (wIPV) which utilize wild-type polioviruses, sIPV offers enhanced biosafety during manufacturing and is more cost-effective. The vaccine was approved for marketing in China in September 2025.
- Other names
- Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin StrainsSabin IPVSabin-strain inactivated poliomyelitis vaccineSabin-strain inactivated poliovirus vaccineSabin株脊髓灰质炎灭活疫苗（Vero细胞）Vero cell-derived IPVsIPV
02
Targets
Poliovirus type 2 capsid protein
Beyond the preview
Go deeper on poliomyelitis vaccine (vero cells), inactivated, sabin strain.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on poliomyelitis vaccine (vero cells), inactivated, sabin strain.